FDA panel recommends injectable drug to prevent RSV in infants
An independent advisory committee to the Food and Drug Administration voted Thursday to recommend an injectable drug that can protect infants up to 2 years old from RSV. The 21-person panel voted unanimously to recommend the shot for newborns and infants during their first months of exposure to…
#rsv #fda #oferlevy #beyfortus #unitedkingdom #astrazeneca #sanofi #georgesiberry #sallyhunsberger #synagis